GGrantIndex
← Leaderboards

Claudia Ordonez

Children'S Hospital Boston

$792,047
Attributed
$792,047
Total exposure
10
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $350K · FY200507
$500K$375K$250K$125K$0
'05
'06
'07

Funding mix

By agency

NIH$442,047 · 9
FDA$350,000 · 1

By mechanism

K23$408,485 · 1
R01$350,000 · 1
M01$33,562 · 8

Top collaborators

No co-investigators on record.

Most similar at Children'S Hospital Boston

Same institution · by research overlap

Others in their field

Top investigators on “Clinical Research

Research focus

Clinical ResearchCystic FibrosisHuman SubjectSputumHuman Therapy EvaluationInflammationPatient Oriented ResearchRespiratory TherapyMetabolism Disorder DiagnosisElastasesAlpha 1 AntitrypsinDiagnostic Respiratory LavageRespiratory Disorder DiagnosisLung DisorderRespiratory FunctionAminoglycoside AntibioticsPathologic ProcessDrug MetabolismDrug Administration Rate /DurationDrug Screening /EvaluationDiagnosis Design /EvaluationFunctional /Structural GenomicsMicroorganism CultureCombination Chemotherapy

Grant awards (21)

Phase 2 study of VX-770 in Cystic Fibrosis Subjectswith G551D$350,000
R01 · FY2007 · FD · contact PI
P aeruginosa virulence in cystic fibrosis lung disease$154,683
K23 · FY2006 · HL · contact PI
ASSESSMENT OF INDUCED SPUTUM AS A TOOL TO EVALUATE ANTI-INFLAMMATORY AGENTS$8,124
M01 · FY2006 · RR · contact PI
FORMULA FORIFIED W/ DOCOSAHEXAENOIC ACID (DHA) IN INFANTS W/ CYSTIC FIBROSIS$3,693
M01 · FY2006 · RR · contact PI
P aeruginosa virulence in cystic fibrosis lung disease$127,443
K23 · FY2005 · HL
TISSUE BANK FOR PULMONARY DISEASES$726
M01 · FY2005 · RR
USE OF SPUTUM IND TO STUDY INFECTION &INFLAM IN CHILD W/CF PHS I&II$726
M01 · FY2005 · RR
P. aeruginosa virulence in cystic fibrosis lung disease$126,359
K23 · FY2004 · HL
Cystic Fibrosis Once Daily Aminoglycoside Clinical Trial (CFODACT)$18,431
M01 · FY2004 · RR
Tissue Bank for Pulmonary Diseases$931
M01 · FY2004 · RR
Study of Airway Inflammation in Subjects with Cystic Fibrosis$559
M01 · FY2004 · RR
USE OF SPUTUM IND. TO STUDY INFECTION &INFLAM. IN CHILD. W/C.F. PHS I&II$186
M01 · FY2004 · RR
Phase I trial comparing two delivery methods and doses of TOBI in CF patients$186
M01 · FY2004 · RR
AIRWAY INFLAMMATION IN CYSTIC FIBROSIS$0
M01 · FY2002 · RR
FREE ELASTASE IN BAL FLUID IN CYSTIC FIBROSIS PATIENTS$0
M01 · FY2002 · RR
FREE ELASTASE IN BAL FLUID IN CYSTIC FIBROSIS PATIENTS$0
M01 · FY2001 · RR
AIRWAY INFLAMMATION IN CYSTIC FIBROSIS$0
M01 · FY2001 · RR
AIRWAY INFLAMMATION IN CYSTIC FIBROSIS$0
M01 · FY2001 · RR
FREE ELASTASE IN BAL FLUID IN CYSTIC FIBROSIS PATIENTS$0
M01 · FY2001 · RR
FREE ELASTASE IN BAL FLUID IN CYSTIC FIBROSIS PATIENTS$0
M01 · FY2000 · RR
AIRWAY INFLAMMATION IN CYSTIC FIBROSIS$0
M01 · FY2000 · RR